The validity of self-reported use of hormone replacement therapy among Danish nurses

Authors


*Ellen Løkkegaard
Center for Alcohol Research
National Institute of Public Health
Svanemøllevej 25
DK-2100 Copenhagen
Denmark
e-mail: loekkegaard@dadlnet.dk

Abstract

Background.  Recent findings from randomized clinical trials on the effects of hormone replacement therapy (HRT) among postmenopausal women contradict findings from observational studies indicating a protective effect on the development of cardiovascular disease. Most observational studies on HRT are based on self-reported data, although data on the validity of HRT in postmenopausal women are sparse.

Methods.  We examined self-reported HRT use from questionnaires administered in 1993 (n = 2694) and again in 1999 (n = 2666) to a cohort of Danish nurses living in two Danish counties compared with prescription-reimbursement data from two administrative databases through the Danish National Health Service.

Results.  The sensitivity and specificity of the self-reported, current HRT use in 1993 were 78.4%[95% confidence interval (95% CI) 75.4–81.4] and 98.4% (95% CI 97.8–98.9), respectively. In 1999, the estimates were 74.8% (95% CI 72.0–77.7) and 98.0% (95% CI 97.3–98.8), respectively. None of the factors examined − including age, alcohol intake, physical activity, smoking, presence of hypertension, and body mass index − was strongly associated with validity. We found a relatively high validity of self-reported data on HRT use. Furthermore, agreement between self-reported and registry-based data was not strongly associated with a range of demographic and lifestyle factors.

Conclusion.  These findings suggest that use of self-reported data is not an important contributor to the apparent discrepancy between observational studies and randomized trials on the cardiovascular effects of HRT use.

Ancillary